Medicollect engaged in British MS study

Medicollect has been asked to help a British pharmaceutical company with finding MS patients to test a new treatment of spasticity. We are thrilled about this and look forward to engaging with British MS patients.

Focus on spasticity

The study tests a new substance to see whether it can relieve spasticity in people with multiple sclerosis. The total duration of the study is approximately 70 days, and during the course of that all patients are seen several times by a MS specialist.
In order to participate, patients must have MS, suffer from spasticity in the legs, and be able to walk a certain distance.

Transportation and expenses are paid in full

Dedicated MS personnel at the following hospitals carry out the study:

  • University College Hospital, London
  • The Royal London, Barts
  • The Walton Centre, Liverpool
  • The Royal Hallamshire Hospital, Sheffield

Participation is with no cost for patients as travel and other study related costs are provided.

Join to learn more

We are looking for people who would like to participate in this study, so if you would like to know more about it, please do not hesitate to fill out our brief online questionnaire.

Medicollect is dedicated to providing the match between patients willing to test new treatments and scientists looking for patients.